Tuberculosis Trial, Recruiting NCT07312266 Sponsor: Barcelona Institute for Global Health Condition: Tuberculosis
Back to Tuberculosis

Tuberculosis Trial, Recruiting

NCT07312266
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people living with HIV (called "index cases"):

  • You are 18 years old or older
  • You have a confirmed HIV diagnosis
  • You are visiting a health facility for your regular HIV care

For Study 3 specifically, you also need to meet these additional conditions:

  • You have been on HIV treatment (antiretroviral therapy) for less than 6 months
  • Your HIV virus levels are not yet under control
  • Your immune cell count (CD4) is above 350
  • Your chest X-ray shows possible signs of TB
  • You currently have no fever or cough, confirmed through symptom checks

For close contacts of index cases:

  • Any close contact (household or community) can be invited to join, regardless of age or HIV status

Who may not be able to join:

For people living with HIV (index cases):

  • You have received treatment for TB in the past 12 months
  • You are currently pregnant
  • You are not willing to give consent for the study procedures
  • You have a medical reason why you cannot have the blood or other samples the study requires (confirm with trial site)

For close contacts:

  • You are planning to move away from the area within the next 12 months
  • You are currently pregnant
  • You are currently taking TB treatment or TB preventive medication
  • You were already found to have TB at the start of the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +34 93 227 1806

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Barcelona Institute for Global Health
Registry
ClinicalTrials.gov
Start date
11 August 2025
Est. completion
1 November 2028

Where this trial is recruiting

Mozambique

Primary endpoints

Proportion of secondary cases arising from TB index case transmission

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov